VFH vs XLV
Vanguard Financials ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.09% for VFH.
- • VFH pays a higher dividend yield (1.77%).
Side-by-side metrics
| Metric | VFH | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.77% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $13.81B | $40.60B |
YTD return | 1.73% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.83 | 0.51 |
P/E ratio | 16.76 | 29.18 |
Last price | $135.99 | $162.17 |
Inception | — | — |
Issuer | Vanguard | State Street |
VFH top holdings
| JPM | JPMorgan Chase & Co | 8.83% |
| BRK-B | Berkshire Hathaway Inc Class B | 7.77% |
| MA | Mastercard Inc Class A | 4.76% |
| BAC | Bank of America Corp | 4.13% |
| V | Visa Inc Class A | 4.10% |
| GS | The Goldman Sachs Group Inc | 3.38% |
| MS | Morgan Stanley | 2.90% |
| WFC | Wells Fargo & Co | 2.80% |
| C | Citigroup Inc | 2.39% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About VFH
VFH (Vanguard Financials ETF) is US financial services sector stocks. Managed by Vanguard, the fund carries $13.8B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.77%. Its largest holding is JPMorgan Chase & Co (JPM), which represents 8.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.8%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.